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The agent that causes bovine spongiform encephalo-
pathy (BSE) may be infecting small ruminants, which could 
have serious implications for human health. To distinguish 
BSE from scrapie and to examine the molecular characteris-
tics of the protease-resistant prion protein (PrPres), we used 
a speciﬁ  cally designed Western blot method to test isolates 
from 648 sheep and 53 goats. During 2002–2009, classi-
cal non-Nor98 transmissible spongiform encephalopathy 
had been conﬁ  rmed among ≈1.7 million small ruminants in 
France. Five sheep and 2 goats that showed a PrPres pat-
tern consistent with BSE, or with the CH1641 experimental 
scrapie source, were identiﬁ  ed. Later, bioassays conﬁ  rmed 
infection by the BSE agent in 1 of the 2 goats. Western blot 
testing of the 6 other isolates showed an additional C-termi-
nally cleaved PrPres product, with an unglycosylated band at 
≈14 kDa, similar to that found in the CH1641 experimental 
scrapie isolate and different from the BSE isolate. 
T
ransmissible spongiform encephalopathies (TSEs) are 
a group of fatal neurodegenerative diseases that include 
scrapie in sheep and goats, bovine spongiform encepha-
lopathy (BSE) in cattle, and Creutzfeldt-Jakob disease 
(CJD) in humans (1,2). TSEs are characterized by accu-
mulation in the brain of a disease-associated isoform (PrPd) 
of a host-encoded cellular prion protein (PrPc) (3). PrPd, 
in comparison with the normal prion protein PrPc, clearly 
differs in secondary and tertiary structures (4,5) and in bio-
chemical characteristics (6). Proteinase K (PK) digestion 
destroys PrPc, but in PrPd it generates a protease-resistant 
fragment known as PrPres. Most TSE diagnostic methods 
(e.g., ELISA and Western blot tests) are based on detection 
of PrPres (7).
The transmissible agent involved in BSE in cattle is 
known to cause prion diseases in other species under natu-
ral conditions (8). BSE can also be experimentally trans-
mitted to sheep and goats, including after oral challenge 
to test for transmission (9). Because BSE-contaminated 
meat and bone meal may have been fed to small ruminants, 
BSE may have been transmitted to sheep or goats. Also, 
the Scientiﬁ  c Steering Committee of the European Com-
mission has hypothesized that the BSE agent might have 
originated from a scrapie agent in sheep or goats and that 
these animals may represent a reservoir (10). In view of 
these data, the European Commission deﬁ  ned a strategy to 
investigate the possible presence of BSE in sheep and goats 
under natural conditions (11).
The standard for strain typing TSE agents is based on 
analysis of the phenotypic characteristics of the disease 
after transmission in laboratory rodents. Biological char-
acterization of the BSE agent in inbred wild-type mice ap-
peared to be reliable, because it showed uniform features 
in mice (8). However, this approach is time-consuming 
and costly. The identiﬁ  cation of uniform molecular fea-
tures of PrPres by Western blot in human variant CJD paved 
the way to a similar approach for detecting possible BSE 
in small ruminants (12). The molecular criteria deﬁ  ned in 
these studies included electrophoretic mobilities, glyco-
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sylation characteristics, and immunolabeling with differ-
ent monoclonal antibodies (13). The last criteria enabled 
mapping of the protease cleavage site of the PrP protein 
fragment obtained after PK digestion (14). More recently, 
the identiﬁ  cation of additional C-terminal PrPres products 
may contribute to discrimination of the different types of 
CJD (15) or of different scrapie and BSE sources (16,17). 
Discriminant molecular features of the prion protein can 
also be investigated by immunohistochemical analysis 
(18) or ELISA (19). In all of these studies, it was assumed 
that the strain information was closely associated with the 
structural features of PrPd.
The Western blot method enabled discrimination of ex-
perimental BSE in sheep from most scrapie-affected animals 
(12,13,20–24). Nevertheless, discrimination was more dif-
ﬁ  cult with the CH1641 experimental scrapie isolate (21,25), 
which otherwise clearly differs from BSE by its absence of 
transmissibility to wild-type mice (26). Similar molecular 
features to those of CH1641 have been described in a few 
natural scrapie cases in France (27) and in the United King-
dom (24). We describe the molecular ﬁ  ndings obtained for 
a large series of TSE infections in France identiﬁ  ed in small 
ruminants by active surveillance during 2002–2009 and for 
CH1641-like isolates in sheep and in 1 goat.
Materials and Methods
Animals and Tissues
Two samples of BSE in small ruminants were used as 
controls, 1 (SB1) from a sheep experimentally infected by 
BSE with a brain homogenate from a BSE-affected cow 
from France (21), and the other (CH41x76) from a goat that 
had been intracerebrally inoculated with a brain homoge-
nate from cattle BSE from Britain (28).
Two experimental scrapie sources in sheep (pro-
vided by N. Hunter, Institute for Animal Health, Edin-
burgh, UK) were also studied. These were the SSBP/1 
scrapie isolate, experimentally maintained by serial pas-
sages in sheep (29), and CH1641 that was derived from a 
Cheviot sheep and then maintained by serial passages in 
sheep (26).
Natural TSE isolates in small ruminants (Table) were 
mainly obtained through an active surveillance program 
in France. In operation since 2002, this program involves 
the random selection and testing of samples from ren-
dering plants and slaughterhouses (30). Some samples 
originated from the passive surveillance program, which 
involves collecting samples from animals showing sus-
pected clinical signs of the disease. Brain stems from all 
selected animals are subjected to a rapid test, and all reac-
tive samples are then retested in the National Reference 
Laboratory by conﬁ  rmatory methods based on Western 
blot (31). When a sample is conﬁ  rmed as TSE positive, it 
is classiﬁ  ed as similar, or not similar, to Nor98 (atypical 
scrapie), according to the PrPres molecular proﬁ  le, which 
in atypical scrapie shows 5 major bands (31). Samples 
that are not similar to Nor98 (classical TSE), i.e, showing 
a 3-band pattern between 19–30 kDa, are then studied by 
using a Western blot discriminatory method to identify 
possible similarities with BSE (11).
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Table. Results of TSE diagnostic tests and molecular characterization for sheep and goats, France, 2002–2009* 
Year Species
No. animals tested 
by rapid tests 
Confirmed TSE 
cases 
Nor98-like 
isolates
Molecular characterization 
Not analyzed  Not defined  Scrapie BSE-like
2002 Ovine 68,580  153 15 0 16 122 0
Caprine 27,087  14 1 0 3 9 1
2003 Ovine 63,207  117 28 0 7 81 1
Caprine 23,161  10 2 0 2 6 0
2004 Ovine 24,639  58 7 3 0 48 0
Caprine 5,730  3 0 0 0 3 0
2005† Ovine 34,290  74 9 19 1 44 1
Caprine 148,338  16 4 2 1 9 0
2006‡ Ovine 492,023  382 182 1 6 190 3
Caprine 165,606  10 1 0 1 8 0
2007§ Ovine 327,894  264 173 1 4 86 0
Caprine 183,498  7 4 0 2 1 0
2008¶ Ovine 86,269 71 45 0 0 26 0
Caprine 79.966  12 8 0 0 3 1
2009 Ovine 55,163  34 22 0 1 11 0
Caprine 52,248  6 3 0 0 3 0
Total Ovine 1,152,065 1,153  481 24 35 608 5
Caprine 685,634  78 23 2 9 42 2
*TSE, transmissible spongiform encephalopathy; BSE, bovine spongiform encephalopathy. 
†January 2005, beginning of exhaustive testing of goats in abattoir and rendering plant. 
‡First quarter 2006, beginning of exhaustive testing of sheep in abattoir and rendering plant. 
§January 2007, end of exhaustive testing of sheep in abattoir. 
¶February 2008, end of exhaustive testing of goats in abattoir and sheep in rendering plant. TSEs of Small Ruminants, France
Western Blot 
All conﬁ   rmed classical TSE (non–Nor98-like) cas-
es were analyzed to determine whether the PrPres looked 
similar to that found in bovine BSE (i.e., showed a low-
er molecular mass than that found in bovine BSE) or, on 
the contrary, was similar as in most scrapie cases. PrPres 
extracts were obtained from animal brains by using Bio-
Rad protocol (the TeSeE Western Blot kit, ref: 355 1169; 
Bio-Rad, Marnes-la-Coquette, France), which is used to 
conﬁ  rm suspected TSE-positive samples and includes PK 
digestion and rapid protein precipitation steps. Denatured 
samples were then loaded on two 15% bis-polyacrylamide 
gels with the same gel plan. After electrophoresis (200 volts 
for 80 min), the proteins were transferred onto a nitrocel-
lulose membrane (R-Biopharm, St. Didier au Mont d’Or, 
France). Blocking was performed for 1 h in 5% (wt/vol) 
milk powder in phosphate-buffered saline (PBS) containing 
0.1 % (vol/vol) Tween-20 (PBS-T) for the membrane to be 
treated with monoclonal antibody Bar233 (1/5000) (144-
FGNDYEDRYYRE-155 ovine PrP sequence) (provided 
by J. Grassi, C.E.A., Saclay, France) or in 3% (wt/vol) 
bovine serum albumin solution (Sigma, St. Quentin-Falla-
vier, France) in PBS-T for the membrane to be treated with 
monoclonal antibody P4 (0.2 mg/mL) (93-WGQGGSH-99 
ovine PrPsequence) (R-Biopharm).
Both antibodies were incubated on the membranes for 
30 min at room temperature. The membranes were then 
washed for 20 min in PBS-T and incubated with a solu-
tion of streptavidine-peroxidase–conjugated antimouse 
immunoglobulin (Southern Biotech distributed by Clini-
sciences, Montrouge, France) in PBS-T for 20 min at room 
temperature. The membranes were then washed for 30 min 
in PBS-T and for 5 min in PBS before detection by use of 
enhanced chemiluminescent substrate (Amersham Biosci-
ences, Orsay, France). The signals were identiﬁ  ed on au-
toradiographic ﬁ  lms (Amersham) after a 3-min exposure. 
Quantitative studies were performed by using Quantity 
One software (Bio-Rad), and the apparent molecular mass-
es were determined by comparing the positions of the PrPres 
bands with a biotinylated marker (B2787) (Sigma). All 
samples were compared, during molecular characteriza-
tion of ﬁ  eld isolates, by expressing the molecular mass of 
the unglycosylated band in terms of differential molecular 
mass (dmm). The dmm corresponds to the difference mea-
sured between the test sample and the control cattle BSE 
sample always loaded beside it.
The possible presence of additional C-terminal PrPres 
products (PrPres #2) (17) was detected and quantiﬁ  ed by de-
glycosylation by using peptide N-glycosidase F (PNGase) 
(kit P07043; BioLabs distributed by Ozyme, Saint-Quen-
tin-en-Yvelines, France) as described (17). The deglyco-
sylated PrPres was detected with SAF84 (0.6 mg/mL) (167-
RPVDQY-172 ovine PrP sequence) (SPI-Bio, Montigny le 
Bretonneux, France) mouse monoclonal antibody. The re-
spective proportions of ≈14- and ≈19-kDa bands, observed 
after PNGase deglycosylation, were quantiﬁ  ed by using 
Quantity One software (Bio-Rad).
Results
Active Surveillance Findings during 2002–2009
Since active surveillance of TSEs in small ruminants 
began in France in 2002, a total of 1,231 small ruminant 
(1,153 sheep and 78 goats) samples have been conﬁ  rmed as 
TSE-positive by Western blot using Sha 31 antibody; >1.7 
million animals have been tested by rapid tests (1,152,065 
sheep and 685,634 goats) (Table). Nearly half of the posi-
tive isolates (504) have been identiﬁ  ed as Nor98 scrapie 
isolates, on the basis of detection of 5 major bands, includ-
ing a prominent ≈10–12 kDa band detected by Western blot 
(32). After conﬁ  rmatory Western blot, insufﬁ  cient quanti-
ties of brain tissue were available for Western blot discrim-
inatory testing in 26 samples, which are shown in the Table 
as samples not analyzed.
The other classical TSE cases, i.e., non–Nor98 cases 
(648 sheep and 53 goats), which typically showed a 3-band 
pattern between 19–30 kDa, have been further character-
ized by applying a discriminatory Western blot method, de-
scribed as the Agence française de sécurité sanitaire des ali-
ments (French Food Safety Agency) discriminatory method 
in the Technical Handbook for National Reference Labora-
tories (33). This method enables rapid identiﬁ  cation of PrPres 
patterns similar to those found in experimental ovine BSE 
and is essentially based on comparison of the PrPres molecu-
lar mass with that of cattle BSE, and comparative labeling 
with 2 antibodies, P4 and Bar233, against either the N ter-
minal end or core part of the PrPres protein, respectively.
Molecular Characterization of Experimental Isolates
 We ﬁ  rst analyzed 4 reference experimental isolates 
in small ruminants: a sheep and a goat with BSE, 2 sheep 
infected with SSBP/1 or CH1641 scrapie sources, and a bo-
vid with classical BSE. The mean molecular masses of the 
diglycosylated (H), monoglycosylated (L), and unglycosy-
lated (U) PrPres bands (using Bar233 antibody) and the P4/
Bar233 differential labeling, as well as the proportions of 
glycoforms, are shown in Figure 1 and in Figure 2, panel 
A. These analyses show the lower molecular mass of the 
unglycosylated PrPres in BSE in sheep (–0.6 kDa) and 1 
goat (–0.5 kDa), and in CH1641 scrapie (–0.8 kDa), com-
pared with the cattle BSE (Figure 1; Figure 2, panel A). In 
contrast, SSBP/1 showed a higher apparent molecular mass 
(+0.6 kDa). The molecular masses of the 3 bands obtained 
for CH1641 (H: –0.8 kDa, L: –0.3 kDa and U: –0.2 kDa) 
were lower than in BSE in sheep or goats. Differential la-
beling by Bar233 and P4 antibodies was correlated with the 
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molecular masses of the protease-resistant cores, with high 
and low Bar233/P4 ratios in SSBP/1 and BSE in sheep, re-
spectively (Figure 1). Like BSE in sheep, CH1641 showed 
a decreased signal with P4 compared with Bar 233. bovine 
BSE showed no labeling with P4 antibody.
Comparison of the proportions of diglycosylated and 
monoglycosylated bands showed the highest levels of 
diglycosylated PrPres in experimental BSE in sheep (75 ± 
9%/18 ± 4%) and goats (71 ± 7%/20 ± 4%), even com-
pared with cattle BSE (64 ± 10%/27 ± 4%) (Figure 2, panel 
D). On the contrary, SSBP/1 showed much lower levels of 
diglycosylated PrPres (46 ± 6%/32 ± 3%), whereas CH1641 
was close to cattle BSE (62 ± 9%/29 ± 5%). 
Experimental BSE in a goat showed the same mo-
lecular features as those observed in experimental BSE 
in sheep. Both molecular masses, P4 immunolabeling and 
glycoforms proportions, were involved (Figure 1; Figure 2, 
panels A, D).
Molecular Characterization of Natural TSE 
Sheep and Goat Isolates
We then compared the cattle BSE control with the 
701 classical samples available for further analyses (648 
sheep and 53 goats). Most of the isolates tested (657) 
were PrPres positive by discriminatory Western blot us-
ing Bar233 core antibody and showed a 3-band pattern, 
whereas the signal was weaker in 44 samples, preventing 
the identiﬁ  cation and characterization of the unglycosy-
lated band.
We chose to express the molecular masses measures 
as dmm, which corresponds to the difference of molecular 
masses measured between the tested sample and the con-
trol cattle BSE always loaded beside it. Most (650) samples 
showed a positive dmm (Figure 3) and strong labeling with 
P4 antibody, as previously described for SSBP/1. However, 
large variations in molecular mass (1.2 kDa) were observed 
among these samples, a possible clue pointing to biologi-
cal diversity among scrapie sources; in contrast, only small 
variations were observed after repeated measures of a same 
sample with the Western blot method, as shown by the 
small standard deviations during repeated analysis of refer-
ence samples (Figure 2). A minority of the samples (12) 
showed similar molecular masses to bovine BSE (dmm 
<0.1 kDa difference). Stronger P4 labeling compared with 
Bar 233 antibody was observed in all these samples and in 
the 44 (not deﬁ  ned) samples for which the dmm could not 
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Figure 1. Immunoblots obtained for reference brain samples by discriminatory Western blot method. The ﬁ  rst membrane (A, B) was 
probed with Bar233 antibody. The second membrane (C, D) was probed with monoclonal antibody P4. The 2 immunoblots were loaded 
with a natural classical bovine spongiform encephalopathy (BSE) isolate (lane 1); an isolate from a sheep experimentally infected with 
classical BSE 4 (SB1, lanes 2, 6); 2 sheep-passaged scrapie isolates (SSBP/1, lanes 3, 5; CH1641, lane 4); and an isolate from a goat 
experimentally infected with classical BSE (CH41x76, lane 7).TSEs of Small Ruminants, France
be measured with Bar233 antibody because quantities of 
extracted PrPres were too low.
A few samples (5 sheep and 2 goats) showed a lower 
PrPres molecular mass than the bovine BSE control, i.e., a 
negative dmm (Figure 3), combined with poor labeling by 
P4 antibody, as described for BSE in small ruminants and 
CH1641 scrapie. These samples were suspected to repre-
sent BSE in small ruminants and were thus further charac-
terized by repeated Western blot analyses in comparison 
with experimental controls.
Molecular Studies of TSE Isolates with 
Low Molecular Mass PrPres
These experiments allowed repeated measures of PrPres 
molecular masses and P4/Bar233 differential labeling and 
estimation of the proportions of PrPres glycoforms. West-
ern blot analyses were also performed with the C-terminal 
SAF84 antibody to identify possible additional C-terminal 
PrPres cleavage products, as described for the CH1641 ex-
perimental isolate (17).
The 3 PrPres glycoforms of the 5 sheep isolates showed 
similar molecular masses close to BSE in sheep or CH1641 
scrapie (Figure 2, panel B; Figure 4, panel A). These simi-
larities of PrPres migration were associated with intermedi-
ate labeling with P4 but nevertheless varied considerably (up 
to 3×) according to the isolate (data not shown). Analyses of 
the glycoform proportions showed lower proportions of the 
diglycosylated band, compared with BSE in sheep, and also 
similarity to CH1641 in this respect (Figure 2, panel E). All 5 
isolates showed an additional ≈14 kDa PrPres band, after use 
of the SAF84 antibody (Figure 4, panel C), that in 4 isolates 
represented 30 ± 7% to 34 ± 7% of the total signal after re-
peated analyses and PNGase deglycosylation. Among these 
sheep isolates, the 06-412 sample showed higher molecular 
masses and proportion of diglycosylated band. Nevertheless, 
the 5 natural isolates thus appeared similar to the CH1641 
experimental scrapie isolate.
For the 2 goat samples with low molecular mass PrPres, 
the molecular characteristics of the CH636 isolate were 
indistinguishable from BSE in goat (CH41x76), with re-
gard to PrPres molecular masses (Figure 5, panel A) and the 
respective proportions of the diglycosylated/monoglycosy-
lated bands (70 ± 9%/22 ± 6% and 71 ± 8%/20 ± 4%, re-
spectively) (Figure 2, panel F) when Bar233 antibody was 
used, and reduced labeling by P4 antibody compared with 
Bar233 (Figure 5, panel B). A similar pattern was observed 
with the other goat sample 08-357, but the levels of the 
diglycosylated band were even higher (83 ± 2%). How-
ever, Western blot analyses with SAF84 antibody showed 
that these 2 goat samples clearly differed and had an ad-
ditional ≈14 kDa PrPres band only in the 08-357 isolate, as 
in the CH1641 experimental scrapie isolate. This ≈14 kDa 
PrPres band was represented in the same proportions as in 
the CH1641-like sheep isolates. This sample could not be 
clearly distinguished from BSE in goat according to other 
molecular criteria.
Discussion
We investigated the PrPres molecular features of one 
of the largest series of natural TSE isolates from sheep and 
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Figure 2. Molecular mass obtained for the di-, mono-, and unglycosylated protein bands (A–C) and the glycoform proportions (D–F) 
between the diglycosylated band and the monoglycosylated band of the protease-resistant prion protein of the reference transmissible 
spongiform encephalopathies isolates (A, D), CH1641-like isolates in sheep (B, E), and unusual isolates in goats (C, F). Results were 
obtained from immunoblots detected by Bar233 antibody. BSE, bovine spongiform encephalopathy.RESEARCH
goats analyzed so far in Europe. Approximately 1.7 million 
small ruminants were subjected to a rapid test; among these, 
1,153 sheep and 78 goats originating from 992 ﬂ  ocks were 
conﬁ  rmed as TSE-positive on the basis of identiﬁ  cation of 
PrPres in the brain stem. Another large study using 1,247 
sheep originating from 450 ﬂ  ocks in Great Britain has been 
reported (24). Similar studies have been conducted in other 
European countries such as Germany (34), the Netherlands 
(14,) and Italy (23), but fewer TSE-positive animals were 
reported. In our series, animals with classical cases repre-
sented 53% of the TSE-affected animals.
The molecular features of most of these isolates (99%) 
were comparable to those previously described for most 
scrapie cases, in studies in Europe or France (21). In all 
of these cases, PrPres from sheep and goats showed clearly 
distinct features from BSE, based on the identiﬁ  cation of a 
higher molecular mass of unglycosylated PrPres, associated 
with strong labeling by the P4 antibody that recognizes the 
N terminal end of the protein. However, our observation 
of large individual variations in this PrPres molecular mass 
implies that a possible relationship with the biologic diver-
sity of TSE agents, which has been described after trans-
mission of scrapie to inbred wild-type mice (35), would be 
questionable. Only a few animals (5 sheep and 2 goats) in 
this large series of TSE-affected animals showed molecular 
characteristics that, in comparison with the usual features 
of scrapie, could be consistent with the known BSE signa-
ture in small ruminants. These samples represented all the 
suspected isolates that were identiﬁ  ed by ofﬁ  cial surveil-
lance in France during 2002–2009.
An essential molecular criterion deﬁ  ned from the ob-
servation of PrPres BSE compared with scrapie was the 
low molecular mass of the unglycosylated band in PrPres 
BSE, associated with a decreased PrPres signal lower 
with an N terminal antibody than with a core antibody 
(13,22,36). After identiﬁ  cation of these molecular fea-
tures in a few small ruminants, only 1 (CH636) of the 2 
cases here described in goats, identiﬁ  ed as TSE positive 
in 2002, has been shown to be infected by the BSE agent 
after bioassays in mice (37). Another goat in the United 
Kingdom identiﬁ  ed by an immunohistochemical discrimi-
natory method as TSE-positive in 1990 showed character-
istics that were indistinguishable from BSE (18). These 
results clearly indicate that in a situation characterized by 
a decrease in the number of cases in cattle in all countries 
in Europe, the possibility of ﬁ  nding BSE in small rumi-
nants is now remote.
The other unusual isolates showed molecular char-
acteristics that were partly similar, not only to BSE in 
small ruminants with a low molecular mass of PrPres and 
faint labeling with P4 antibody, but also to the CH1641 
experimental scrapie isolate. However, detailed immuno-
histochemical investigations of CH1641 showed subtle 
differences in the cleavage site of the protein compared 
with BSE in sheep (38). As previously described, after 
transmission in ovine transgenic mice (17), the slightly 
lower PrPres molecular mass in CH1641-like isolates, as 
recognized in the CH1641 experimental isolate (13),was 
conﬁ  rmed by Western blot, at least in sheep (Figure 2, 
panel B). However, these differences in molecular mass 
are more easily identiﬁ   ed on the diglycosylated band. 
Compared with BSE in small ruminants, lower propor-
tions of this diglycosylated band were found in sheep, 
whereas the 08-357 goat sample showed very high levels 
of this diglycosylated band, which would be consistent 
with BSE. Experimental transmissions of BSE in sheep 
have shown that, to a certain extent, the PrPres molecu-
lar features could be inﬂ  uenced by different factors, such 
as serial passages in sheep (39) or sheep genotypes (36), 
although slight variability did not compromise the dis-
crimination with scrapie. Furthermore, all these CH1641-
like natural isolates in sheep and goats clearly differed 
from BSE by the presence of an additional, C-terminally 
cleaved, PrPres product speciﬁ  cally recognized by a C-
terminal antibody (SAF84), as previously described for 
the CH1641 experimental scrapie isolate (17). Baron et al. 
described bioassays of 3 CH1641-like sheep isolates (17), 
which are also being conducted for the other isolates.
These 6 CH1641-like isolates were identiﬁ  ed among 
1,153 sheep and 78 goats with conﬁ  rmed TSE, and the 
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Figure 3. Differences in molecular 
mass observed between protease-
resistant prion protein in cattle bovine 
spongiform encephalopathy (BSE) 
and usual transmissible spongiform 
encephalopathy cases in small 
ruminants. Differential molecular 
mass was obtained by subtracting the 
molecular mass of the unglycosylated 
band of the cattle BSE control to that of 
the natural small ruminant isolate from 
an immunoblot detected by Bar233 
antibody. TSEs of Small Ruminants, France
goat case represents, to our knowledge, a spreading of the 
known species range for natural CH1641 infection. At 
least in sheep, for which 4.34 cases per million sheep test-
ed were identiﬁ  ed in this study, the frequency of CH1641-
like scrapie was notably higher compared with other rare 
TSEs in ruminants such as atypical BSEs, which showed 
a frequency of 0.76 per million cattle tested during 2001–
2007 (40). Thus, large-scale testing of animals would be 
required to identify these rare TSE isolates. Similar iso-
lates were only identiﬁ  ed in sheep in the other large series 
reported from 450 ﬂ  ocks in Great Britain (2 cases in 1 
ﬂ  ock) (23) and in a previous study of 214 TSE-infected 
sheep in France (2 cases in 1 ﬂ  ock) (27). However, an 
underestimation of the frequency of such cases cannot be 
fully excluded. PrPres features are assessed by analyzing a 
single homogenate prepared from a brain fragment from 
the animal. Stack et al. described a case in sheep that ap-
peared as CH1641-like after repeated Western blot analy-
sis of a brain stem sample, whereas previous analysis of 
the caudal medulla at the time of submission had shown 
the usual scrapie proﬁ  le (24). Immunohistochemical test-
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Figure 5. Western blot analysis of protease-resistant prion protein 
in 2 goat isolates (CH636, lane 3; 08-357, lane 4) detected by 
Bar233 (A), P4 (B), and SAF84 (C) antibodies. These samples 
were compared with an isolate from a goat naturally infected with 
scrapie (lane 1); an isolate from a goat experimentally infected with 
classical BSE (CH41x76, lane 2); and a sheep-passaged scrapie 
isolate (CH1641, lane 5). Samples in panel C were deglycosylated 
with peptide N-glycosidase F before Western blot analysis.
Figure 4. Western blot analysis of protease-resistant prion protein 
in 2 CH1641-like sheep isolates (06-017, lane 3; 06-287, lane 4) 
detected by Bar233 (A), P4 (B), and SAF84 (C) antibodies. These 
samples were compared with 2 sheep-passaged scrapie isolates 
(SSBP/1, lane 1; CH1641, lane 5) and an isolate from a sheep 
experimentally infected with classical spongiform encephalopathy 
(SB1, lane 2). Samples in panel C were deglycosylated with peptide 
N-glycosidase F before Western blot analysis.RESEARCH
ing of 2 CH1641-like cases in sheep showed, that unlike 
BSE, PrPd could be clearly identiﬁ  ed by using P4 antibody 
in some of the brain stem nuclei and in lymphoid tissues 
(27). Finally, on the basis of identiﬁ  cation of low levels 
of C-terminal PrPres product in ovine transgenic mice in-
fected with usual scrapie isolates, we hypothesized that 
a CH1641-like component might be present as a minor 
component in these scrapie cases that showed usual mo-
lecular features (17). All these data raise the question of 
the existence of possible mixtures of TSE agents in these 
particular CH1641-like isolates. 
Acknowledgments
We are grateful to Jeremy Verchère, Michele Lavoine, and 
Claire Aufauvre for their contributions in the Western blot experi-
ments.
Mr Vulin is a PhD candidate at the Agence Nationale de 
Sécurité Sanitaire, Lyon, France. His research focuses on stud-
ies of prion diseases of ruminants, including characterization of 
the disease-associated prion protein, with particular emphasis on 
unusual forms of these diseases.
References
  1.   Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analy-
sis of prion strain variation and the aetiology of ‘new variant’ CJD. 
Nature. 1996;383:685–90. DOI: 10.1038/383685a0
  2.   Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge 
J, et al. The same prion strain causes vCJD and BSE. Nature. 
1997;389:448–50, 526. DOI: 10.1038/38925
  3.   Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–83. 
DOI: 10.1073/pnas.95.23.13363
  4.   Caughey B, Raymond GJ. The scrapie-associated form of PrP is 
made from a cell surface precursor that is both protease- and phos-
pholipase-sensitive. J Biol Chem. 1991;266:18217–23.
  5.   Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K. NMR 
characterization of the full-length recombinant murine prion protein, 
mPrP(23–231). FEBS Lett. 1997;413:282–8. DOI: 10.1016/S0014-
5793(97)00920-4
  6.   Riesner D. Biochemistry and structure of PrP(C) and PrP(Sc). Br 
Med Bull. 2003;66:21–33. DOI: 10.1093/bmb/66.1.21
  7.   Gavier-Widen D, Stack MJ, Baron T, Balachandran A, Simmons M. 
Diagnosis of transmissible spongiform encephalopathies in animals: 
a review. J Vet Diagn Invest. 2005;17:509–27.
  8.   Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. 
Transmission of bovine spongiform encephalopathy and scrapie to 
mice: strain variation and the species barrier. Philos Trans R Soc 
Lond B Biol Sci. 1994;343:405–11. DOI: 10.1098/rstb.1994.0036
  9.   Foster JD, Hope J, Fraser H. Transmission of bovine spongiform en-
cephalopathy to sheep and goats. Vet Rec. 1993;133:339–41. DOI: 
10.1136/vr.133.14.339
10.  Opinion of the Scientiﬁ  c Steering Committee of the European Com-
mission on Hypotheses on the Origin and Transmission of BSE. Eu-
ropean Commission, adopted 29–30 Nov 2001. http://ec.europa.eu/
food/fs/sc/ssc/out236_en.pdf
11.  Opinion of the Scientiﬁ  c Steering Committee of the European Com-
mission on Strategy to Investigate the Possible Presence of BSE in 
Sheep. European Commission, adopted on 4–5 Apr 2002. http://
ec.europa.eu/food/fs/sc/ssc/out281_en.pdf
12.   Hill AF, Sidle KC, Joiner S, Keyes P, Martin TC, Dawson M, et al. 
Molecular screening of sheep for bovine spongiform encephalopa-
thy. Neurosci Lett. 1998;255:159–62. DOI: 10.1016/S0304-3940
(98)00736-8
13.    Stack MJ, Chaplin MJ, Clark J. Differentiation of prion protein 
glycoforms from naturally occurring sheep scrapie, sheep-passaged 
scrapie strains (CH1641 and SSBP1), bovine spongiform enceph-
alopathy (BSE) cases, and Romney and Cheviot breed sheep ex-
perimentally inoculated with BSE using two monoclonal antibodies. 
Acta Neuropathol. 2002;104:279–86.
14.   Thuring CM, Erkens JH, Jacobs JG, Bossers A, Van Keulen LJ, Gars-
sen GJ, et al. Discrimination between scrapie and bovine spongiform 
encephalopathy in sheep by molecular size, immunoreactivity, and 
glycoproﬁ  le of prion protein. J Clin Microbiol. 2004;42:972–80. 
DOI: 10.1128/JCM.42.3.972-980.2004
15.   Notari S, Strammiello R, Capellari S, Giese A, Cescatti M, Grassi 
J, et al. Characterization of truncated forms of abnormal prion pro-
tein in Creutzfeldt-Jakob disease. J Biol Chem. 2008;283:30557–65. 
DOI: 10.1074/jbc.M801877200
16.   Biacabe AG, Jacobs JG, Bencsik A, Langeveld JP, Baron TG. H-type 
bovine spongiform encephalopathy: complex molecular features and 
similarities with human prion diseases. Prion. 2007;1:61–8. DOI: 
10.4161/pri.1.1.3828
17.   Baron T, Bencsik A, Vulin J, Biacabe AG, Morignat E, Verchere J, 
et al. A C-terminal protease-resistant prion fragment distinguishes 
ovine “CH1641-like” scrapie from bovine classical and L-Type BSE 
in ovine transgenic mice. PLoS Pathog. 2008;4:e1000137. DOI: 
10.1371/journal.ppat.1000137
18.  Jeffrey M, Martin S, Gonzalez L, Foster J, Langeveld JP, van Zijder-
veld FG, et al. Immunohistochemical features of PrP(d) accumula-
tion in natural and experimental goat transmissible spongiform en-
cephalopathies. J Comp Pathol. 2006;134:171–81. DOI: 10.1016/j.
jcpa.2005.10.003
19.   Simon S, Nugier J, Morel N, Boutal H, Creminon C, Benestad SL, et 
al. Rapid typing of transmissible spongiform encephalopathy strains 
with differential ELISA. Emerg Infect Dis. 2008;14:608–16. DOI: 
10.3201/eid1404.071134
20.   Baron TG, Madec JY, Calavas D. Similar signature of the prion pro-
tein in natural sheep scrapie and bovine spongiform encephalopathy-
linked diseases. J Clin Microbiol. 1999;37:3701–4.
21.   Baron TG, Madec JY, Calavas D, Richard Y, Barillet F. Comparison 
of French natural scrapie isolates with bovine spongiform enceph-
alopathy and experimental scrapie infected sheep. Neurosci Lett. 
2000;284:175–8. DOI: 10.1016/S0304-3940(00)01047-8
22.   Baron TG, Biacabe AG. Molecular analysis of the abnormal prion 
protein during coinfection of mice by bovine spongiform encephal-
opathy and a scrapie agent. J Virol. 2001;75:107–14. DOI: 10.1128/
JVI.75.1.107-114.2001
23.   Nonno R, Esposito E, Vaccari G, Conte M, Marcon S, Di Bari M, et 
al. Molecular analysis of cases of Italian sheep scrapie and compari-
son with cases of bovine spongiform encephalopathy (BSE) and ex-
perimental BSE in sheep. J Clin Microbiol. 2003;41:4127–33. DOI: 
10.1128/JCM.41.9.4127-4133.2003
24.   Stack M, Jeffrey M, Gubbins S, Grimmer S, Gonzalez L, Martin S, 
et al. Monitoring for bovine spongiform encephalopathy in sheep 
in Great Britain, 1998–2004. J Gen Virol. 2006;87:2099–107. DOI: 
10.1099/vir.0.81254-0
25.   Hope J, Wood SC, Birkett CR, Chong A, Bruce ME, Cairns D, et al. 
Molecular analysis of ovine prion protein identiﬁ  es similarities be-
tween BSE and an experimental isolate of natural scrapie, CH1641. 
J Gen Virol. 1999;80:1–4.
26.   Foster JD, Dickinson AG. The unusual properties of CH1641, a 
sheep-passaged isolate of scrapie. Vet Rec. 1988;123:5–8. DOI: 
10.1136/vr.123.1.5
62  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011TSEs of Small Ruminants, France
27.   Lezmi S, Martin S, Simon S, Comoy E, Bencsik A, Deslys JP, et 
al. Comparative molecular analysis of the abnormal prion protein in 
ﬁ  eld scrapie cases and experimental bovine spongiform encephalop-
athy in sheep by use of Western blotting and immunohistochemical 
methods. J Virol. 2004;78:3654–62. DOI: 10.1128/JVI.78.7.3654-
3662.2004
28.   Foster J, Goldmann W, Parnham D, Chong A, Hunter N. Partial 
dissociation of PrP(Sc) deposition and vacuolation in the brains 
of scrapie and BSE experimentally affected goats. J Gen Virol. 
2001;82:267–73.
29.   Hunter N, Foster JD, Dickinson AG, Hope J. Linkage of the gene for 
the scrapie-associated ﬁ  bril protein (PrP) to the Sip gene in Cheviot 
sheep. Vet Rec. 1989;124:364–6. DOI: 10.1136/vr.124.14.364
30.   Morignat E, Cazeau G, Biacabe AG, Vinard JL, Bencsik A, Madec 
JY, et al. Estimates of the prevalence of transmissible spongiform 
encephalopathies in sheep and goats in France in 2002. Vet Rec. 
2006;158:683–7. DOI: 10.1136/vr.158.20.683
31.   Arsac JN, Biacabe AG, Nicollo J, Bencsik A, Baron T. Biochemical 
identiﬁ  cation of bovine spongiform encephalopathies in cattle. Acta 
Neuropathol. 2007;114:509–16. DOI: 10.1007/s00401-007-0270-1
32.   Arsac JN, Andreoletti O, Bilheude JM, Lacroux C, Benestad SL, 
Baron T. Similar biochemical signatures and prion protein genotypes 
in atypical scrapie and Nor98 cases, France and Norway. Emerg In-
fect Dis. 2007;13:58–65. DOI: 10.3201/eid1301.060393
33.  Community Reference Laboratory of the European Union. Dis-
criminatory testing handbook. TSE strain characterisation in small 
ruminants—a technical handbook for national reference laboratories 
in the EU. Version 3. 2009 March.
34.   Gretzschel A, Buschmann A, Eiden M, Ziegler U, Luhken G, Er-
hardt G, et al. Strain typing of German transmissible spongiform 
encephalopathies  ﬁ   eld cases in small ruminants by biochemical 
methods. J Vet Med B Infect Dis Vet Public Health. 2005;52:55–63. 
DOI: 10.1111/j.1439-0450.2005.00827.x
35.   Bruce ME, Boyle A, Cousens S, McConnell I, Foster J, Goldmann 
W, et al. Strain characterization of natural sheep scrapie and com-
parison with BSE. J Gen Virol. 2002;83:695–704.
36.   Ronzon F, Bencsik A, Lezmi S, Vulin J, Kodjo A, Baron T. BSE 
inoculation to prion diseases–resistant sheep reveals tricky silent 
carriers. Biochem Biophys Res Commun. 2006;350:872–7. DOI: 
10.1016/j.bbrc.2006.09.137
37.   Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, et al. 
BSE agent signatures in a goat. Vet Rec. 2005;156:523–4.
38.   Jeffrey M, Gonzalez L, Chong A, Foster J, Goldmann W, Hunter N, 
et al. Ovine infection with the agents of scrapie (CH1641 isolate) 
and bovine spongiform encephalopathy: immunochemical simi-
larities can be resolved by immunohistochemistry. J Comp Pathol. 
2006;134:17–29. DOI: 10.1016/j.jcpa.2005.06.005
39.   Stack M, Gonzalez L, Jeffrey M, Martin S, Macaldowie C, Chaplin 
M, et al. Three serial passages of bovine spongiform encephalopathy 
in sheep do not signiﬁ  cantly affect discriminatory test results. J Gen 
Virol. 2009;90:764–8. DOI: 10.1099/vir.0.005983-0
40.   Biacabe AG, Morignat E, Vulin J, Calavas D, Baron TG. Atypical 
bovine spongiform encephalopathies, France, 2001–2007. Emerg 
Infect Dis. 2008;14:298–300. DOI: 10.3201/eid1402.071141
Address for correspondence: Thierry Baron, Agence Nationale de Sécurité 
Sanitaire, Unité ATNC, 69364 Lyon CEDEX 07, France; email: thierry.
baron@anses.fr
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011  63 